Company Registration No. 4567617 (England and Wales)
Cochrane Opportunity Enterprises Limited
Unaudited accounts
for the year ended 31 March 2025
Cochrane Opportunity Enterprises Limited
Unaudited accounts
Contents
Cochrane Opportunity Enterprises Limited
Company Information
for the year ended 31 March 2025
Company Number
4567617 (England and Wales)
Registered Office
5 Commercial Street
Ystradgynlais
Swansea
SA9 1HD
United Kingdom
Accountants
RGS Accountants Limited
5 Commercial Street
Ystradgynlais
Swansea
SA9 1HD
Cochrane Opportunity Enterprises Limited
Statement of financial position
as at 31 March 2025
Tangible assets
351,900
351,900
Investments
868,688
730,000
Cash at bank and in hand
135,393
121,368
Creditors: amounts falling due within one year
(22,367)
(5,930)
Net current assets
384,796
465,102
Net assets
1,605,384
1,547,002
Called up share capital
2
2
Profit and loss account
1,605,382
1,547,000
Shareholders' funds
1,605,384
1,547,002
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 21 September 2025 and were signed on its behalf by
Lyndsay Cochrane
Director
Company Registration No. 4567617
Cochrane Opportunity Enterprises Limited
Notes to the Accounts
for the year ended 31 March 2025
Cochrane Opportunity Enterprises Limited is a private company, limited by shares, registered in England and Wales, registration number 4567617. The registered office is 5 Commercial Street, Ystradgynlais, Swansea, SA9 1HD, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
Reducing balance: 25% per annum
4
Tangible fixed assets
Land & buildings
5
Investments
Other investments
Valuation at 1 April 2024
730,000
Valuation at 31 March 2025
868,688
Cochrane Opportunity Enterprises Limited
Notes to the Accounts
for the year ended 31 March 2025
Amounts falling due within one year
Other debtors
65,394
103,152
Amounts falling due after more than one year
Other debtors
206,376
246,512
7
Creditors: amounts falling due within one year
2025
2024
Taxes and social security
19,967
3,530
Other creditors
2,400
2,400
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).